These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29513046)

  • 1. A microemulsion of puerarin-phospholipid complex for improving bioavailability: preparation, in vitro and in vivo evaluations.
    Wu JY; Li YJ; Han M; Hu XB; Yang L; Wang JM; Xiang DX
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1336-1341. PubMed ID: 29513046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced oral bioavailability of puerarin using microemulsion vehicle.
    Wu H; Lu C; Zhou A; Min Z; Zhang Y
    Drug Dev Ind Pharm; 2009 Feb; 35(2):138-44. PubMed ID: 19040180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of microemulsion enhancing the oral bioavailability of puerarin: comparison between oil-in-water and water-in-oil microemulsions using the single-pass intestinal perfusion method and a chylomicron flow blocking approach.
    Tang TT; Hu XB; Liao DH; Liu XY; Xiang DX
    Int J Nanomedicine; 2013; 8():4415-26. PubMed ID: 24277986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation optimization and bioavailability after oral and nasal administration in rabbits of puerarin-loaded microemulsion.
    Yu A; Wang H; Wang J; Cao F; Gao Y; Cui J; Zhai G
    J Pharm Sci; 2011 Mar; 100(3):933-41. PubMed ID: 20862776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics and bioavailability of Puerarin self-microemulsion in Beagle dogs].
    Chen XX; Yuan S; Li G; Liang YY; Zhou X; Xie CS; Long CF
    Zhong Yao Cai; 2011 May; 34(5):750-3. PubMed ID: 21954564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation optimization of self-emulsifying preparations of puerarin through self-emulsifying performances evaluation in vitro and pharmacokinetic studies in vivo.
    Quan DQ; Xu GX
    Yao Xue Xue Bao; 2007 Aug; 42(8):886-91. PubMed ID: 17944241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-trimethyl chitosan (TMC)-modified microemulsions for improved oral bioavailability of puerarin: preparation and evaluation.
    Liao D; Liu X; Dai W; Tang T; Ou G; Zhang K; Han M; Kang R; Yang S; Xiang D
    Drug Deliv; 2015; 22(4):516-21. PubMed ID: 24467620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation development and pharmacokinetics of puerarin self-emulsifying drug delivery systems.
    Dong-Qin Q; Gui-Xia X; Xiang-Gen W
    PDA J Pharm Sci Technol; 2007; 61(1):37-43. PubMed ID: 17390702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic, tissue distribution, and excretion of puerarin and puerarin-phospholipid complex in rats.
    Li Y; Pan WS; Chen SL; Xu HX; Yang DJ; Chan AS
    Drug Dev Ind Pharm; 2006 Apr; 32(4):413-22. PubMed ID: 16638679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyamidomine dendrimers: an excellent drug carrier for improving the solubility and bioavailability of puerarin.
    Gu L; Wu Zh; Qi X; He H; Ma X; Chou X; Wen X; Zhang M; Jiao F
    Pharm Dev Technol; 2013; 18(5):1051-7. PubMed ID: 22303809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and evaluation of self-microemulsifying sustained-release pellet formulation of puerarin for oral delivery.
    Zhang Y; Wang R; Wu J; Shen Q
    Int J Pharm; 2012 May; 427(2):337-44. PubMed ID: 22366381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preparation of puerarin liposome and its oral absorption in rat].
    Gu YZ; Zhou W; Zhai GX
    Zhong Yao Cai; 2007 Aug; 30(8):970-3. PubMed ID: 18074848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration.
    Luo CF; Yuan M; Chen MS; Liu SM; Zhu L; Huang BY; Liu XW; Xiong W
    Int J Pharm; 2011 May; 410(1-2):138-44. PubMed ID: 21392565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation of puerarin solid self-microemulsion].
    Yu AH; Zhai GX; Cui J; Liu H
    Zhong Yao Cai; 2006 Aug; 29(8):834-8. PubMed ID: 17076244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of particle size on the pharmacokinetics of puerarin nanocrystals and microcrystals after oral administration to rat.
    Tu L; Yi Y; Wu W; Hu F; Hu K; Feng J
    Int J Pharm; 2013 Dec; 458(1):135-40. PubMed ID: 24120729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and optimization of intravenous puerarin emulsions formation by a novel complex-phase inversion-homogenization technology.
    Yue PF; Yuan HL; Li XY; Yang M; Zhu WF; Xiao XH
    Chem Pharm Bull (Tokyo); 2007 Nov; 55(11):1563-8. PubMed ID: 17978512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on effect of microemulsion in enhancing solubility of baicalin and puerarin].
    Yang H; Yi H; Li ML; Cao ZY; Feng WH
    Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):1996-9. PubMed ID: 18161289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of Phospholipid Complex and Submicron Emulsion Techniques for Improving Oral Bioavailability and Therapeutic Efficacy of Water-Insoluble Drug.
    Qin L; Niu Y; Wang Y; Chen X
    Mol Pharm; 2018 Mar; 15(3):1238-1247. PubMed ID: 29412674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on preparation and absolute bioavailability of a self-emulsifying system containing puerarin.
    Quan DQ; Xu GX; Wu XG
    Chem Pharm Bull (Tokyo); 2007 May; 55(5):800-3. PubMed ID: 17473473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.